Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Clinical and Experimental Nephrology
Published in: Clinical and Experimental Nephrology 6/2017

01-12-2017 | Retraction Note

Retraction Note to: Risk factors for increased left ventricular hypertrophy in patients with chronic kidney disease

Authors: Kosaku Nitta, Satoshi Iimuro, Enyu Imai, Seiichi Matsuo, Hirofumi Makino, Tadao Akizawa, Tsuyoshi Watanabe, Yasuo Ohashi, Akira Hishida

Published in: Clinical and Experimental Nephrology | Issue 6/2017

Login to get access

Excerpt

The editorial board has decided to retract the above-cited article entitled “Risk factors for increased left ventricular hypertrophy in patients with chronic kidney disease”, doi:10.​1007/​s10157-012-0758-4, because of an inadvertent but serious error. …
Metadata
Title
Retraction Note to: Risk factors for increased left ventricular hypertrophy in patients with chronic kidney disease
Authors
Kosaku Nitta
Satoshi Iimuro
Enyu Imai
Seiichi Matsuo
Hirofumi Makino
Tadao Akizawa
Tsuyoshi Watanabe
Yasuo Ohashi
Akira Hishida
Publication date
01-12-2017
Publisher
Springer Japan
Published in
Clinical and Experimental Nephrology / Issue 6/2017
Print ISSN: 1342-1751
Electronic ISSN: 1437-7799
DOI
https://doi.org/10.1007/s10157-017-1466-x

Other articles of this Issue 6/2017

Clinical and Experimental Nephrology 6/2017 Go to the issue

Original article

A minimal impact of long-term S-flurbiprofen plaster application on kidney function in osteoarthritis patients

Original article

Serum ferritin as an indicator of the development of encephalopathy in enterohemorrhagic Escherichia coli-induced hemolytic uremic syndrome

Erratum

Erratum to: Impact of hemoglobin levels on renal and non-renal clinical outcomes differs by chronic kidney disease stages: the Gonryo study

Original article

Preemptive kidney transplantation: a propensity score matched cohort study

Original article

Outcomes of diuretic use in pre-dialysis CKD patients with moderate renal deterioration attending tertiary care referral center

Letter to the editor

Reproducibility for pathological prognostic parameters of the Oxford classification of IgA nephropathy: statistical issue

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits